+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Idiopathic Pulmonary Fibrosis

  • ID: 4483051
  • Book
  • August 2018
  • Elsevier Health Science

Designed with the practicing clinician in mind, Idiopathic Pulmonary Fibrosis provides a succinct, easy-to-digest overview of this challenging condition in which the cause of thickening lung tissue is unknown. This concise resource by Drs. Kevin K. Brown and Jeff Swigris provides essential information for the physician who sees pulmonary fibrosis patients, including epidemiology, genetics and biomarkers, pathology, diagnosis, disease monitoring, and therapeutics intended to improve the patient's lifespan and quality of life.

  • Covers the process of making the diagnosis of idiopathic pulmonary fibrosis, as well as IPF look-alikes: uncharacterized PF, CTD-ILD, and cHP.
  • Details today's available therapeutics, including Rx, rehabilitation, O2, Tx, and treating comorbidities: OSA, GERD, and PH.
  • Consolidates today's available information on this timely topic into one convenient resource.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Note: Product cover images may vary from those shown

1. Introduction

2. Epidemiology of IPF/ILD

3. Mechanisms of Fibrosis

4. Genetics of IPF

5. HRCT in IPF

6. Pathology of IPF

7. Making the Diagnosis of IPF

8. IPF Look-Alikes: Uncharacterized PF, CTD-ILD and cHP

9. Natural History of IPF and Disease Monitoring

10. Biomarkers in IPF

11. Therapeutics (Rx, Rehabilitation, O2, Tx, and Treating Comorbidities: OSA, GERD, PH)
Note: Product cover images may vary from those shown
Jeffrey Swigris
Kevin K Brown National Jewish Health.
Note: Product cover images may vary from those shown